Impact of mobile phone intervention on intermittent preventive treatment of malaria during pregnancy in Burkina Faso : A pragmatic randomized trial |
| |
| Affiliation: | 1. Université Joseph Ki-ZERBO, Ouagadougou, Burkina Faso;2. Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso;3. Faculty of Infectious and Tropical Diseases, Disease Control Department, London School of Hygiene and Tropical Medicine, WC1E 7HT, London, UK;4. Institut de Recherche Clinique du Bénin (IRCB), Abomey-Calavi, Benin;5. Centre Hospitalier Universitaire de Bogodogo, Ouagadougou, Burkina Faso;6. Medical Research Council at London School of Hygiene and Tropical Medicine, Banjul, Gambia;7. Programme d''appui au développement sanitaire (PADS), Ministère de la santé, Ouagadougou, Burkina Faso;8. MERIT- Mère et Enfant Face aux Infections Tropicales, Institut de Recherche pour le Développement, Paris, France, Université Paris Descartes, Sorbonne Paris Cité, France;9. Institut Africain de Santé Publique, Ouagadougou, Burkina Faso;1. Higher Institute of Nursing Professions and Health Techniques, Marrakech, Morocco;2. Laboratory of Cell Biology and Molecular Genetics, Department of Biology, Faculty of Sciences, University Ibn Zohr, Agadir, Morocco;3. Higher Institute of Nursing Professions and Health Techniques, Agadir, Morocco;4. Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy of Rabat, Mohammed V University of Rabat, Morocco;5. Applied Geosciences and Environment Team, Faculty of Agadir Sciences, IBN ZOHR University, Agadir, Morocco;6. Laboratory of Community health, preventive medicine and hygiene, Department of public health, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco;7. Medical Biology, Human and Experimental Pathology and Environment, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco;1. Laboratory of Biostatistics, Clinical Research and Epidemiology, Faculty of Medicine and Pharmacy of Rabat, Mohamed V University, Rabat 10100, Morocco;2. Laboratory of Social Medicine (Public Health, Hygiene and Preventive Medicine), Faculty of Medicine and Pharmacy of Rabat, Mohamed V University, Rabat 10100, Morocco;3. Laboratory of Community Medicine, Preventive Medicine, Public Health and Hygiene, Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir 80060, Morocco;4. High Institute of Nursing Professions and Technical Health, Agadir, Morocco;1. Bordeaux Population Health Research Center. UMR 1219 CIC-EC 1401, Université de Bordeaux, 33000 Bordeaux, France;2. Prevention Chair, ISPED, University of Bordeaux, 33000 Bordeaux, France;3. Ecole des hautes études en santé publique (EHESP), 35000 Rennes, France;4. Secrétariat général des ministères chargés des affaires sociales (SGMAS), 75000 Paris, France;5. Caisse nationale d''assurance maladie (Cnam), 75000 Paris, France;6. Prevention department, CHU, 33000 Bordeaux, France;1. Unité Parasitologie et entomologie, Département Microbiologie et maladies infectieuses, Institut de recherche biomédicale des armées, Marseille, France;2. Aix-Marseille Université, IRD, SSA, AP-HM, VITROME, Marseille, France;3. IHU Méditerranée Infection, Marseille, France;4. Fédération des laboratoires, Hôpital Principal de Dakar, Dakar, Senegal;5. Centre national de reference du paludisme, Marseille, France;6. Service des urgences, Hôpital Principal de Dakar, Dakar, Senegal;7. Service de réanimation médicale, Hôpital Principal de Dakar, Dakar, Senegal;8. Laboratoire d''analyses médicales, Institut Pasteur de Dakar, Dakar, Senegal;9. Service de maternité, Hôpital Principal de Dakar, Dakar, Senegal;10. Centre medical inter-armées Lemonier, Dakar, Senegal;11. Institut de recherche en santé, de surveillance épidémiologique et de formation (IRESSEF), Dakar, Senegal;12. Service de pathologies infectieuses, Hôpital Principal de Dakar, Dakar, Senegal;1. Université de Bordeaux, ISPED, F-33000 Bordeaux, France;2. Inserm, ISPED, Centre Inserm U1219-Bordeaux Population Health, F-33000 Bordeaux, France;3. Consultant, F-74940 Annecy-Le-Vieux, France;4. CHU de Bordeaux, Pôle de Santé Publique, Service d''information médicale, F-33000 Bordeaux, France |
| |
| Abstract: | PurposeIntermittent preventive treatment of malaria with sulphadoxine-pyrimethamine for pregnant women (IPTp-SP) coverage remains far below the desirable goal of at least three doses before delivery. This study evaluates an innovative intervention using mobile phones as a means of increasing coverage for the third dose of IPTp-SP.MethodsThis study in Burkina Faso was designed as an open-label, pragmatic, two-arm, randomised trial. Pregnant women who attended antenatal clinic (ANC) visits were included at their first ANC visit and followed until delivery. The intervention was built around the use of mobile phones as means ensuring direct tracking of pregnant women.ResultsTwo hundred and forty-eight (248) pregnant women were included in the study. The proportion of women who received at least three doses of IPTp-SP was 54.6 %. In the intervention group, 54.1 % of women received at least three doses of IPTp-SP versus 55.1 % in the control group, a non-significant difference (adjusted odds ratio “aOR”, 0.86 ; 95 % confidence interval “95 % CI”, 0.49–1.51). Women in the intervention group were more likely to carry out their ANC visits in a timely manner than those in the control group (aOR, 3.21 ; 95 % CI, 1.91–5.39).ConclusionWhile mobile phone intervention did not increase the proportion of women receiving three doses of IPTp-SP, it did help to increase the proportion of timely ANC visits.Trial registrationPACTR202106905150440 |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
